Management Team and Board of Directors
Peter Lanciano, Executive Director, formerly Co-founder, Chairman, and CEO of Altus Pharmaceuticals, In 2006, he became Executive Director of Neotropix, Inc., a position he still currently retains.
William F. Crowley, Jr. M.D., co-founder, Chairman, Clinical Advisory Board
Professor of Medicine, Harvard Medical School
Robert Langer, Ph.D., Co-founder, Board of Directors, Institute Professor, Massachusetts Institute of Technology
Elizabeth Bailey, Board of Directors Observer, Principal, Common Capital.
Sena Biswas, Ph.D. – Chairman, Board of Directors, Managing Director, Life Sciences, VIMAC Ventures.
Eyal Ron, Ph.D. , Interim CTO, CSO/COO Cerebrotec, eNOS Pharmaceuticals, GelMed, InfiMed, Genetics Institute
John Ledoux, Director of Finance, formerly Controller Altus Pharmaceuticals, CFO of Quantic Communications.
| 
